Research ArticleArticle
Antinuclear Antibodies Testing Method Variability: A Survey of Participants in the College of American Pathologists’ Proficiency Testing Program
Stanley J. Naides, Jonathan R. Genzen, Gyorgy Abel, Christine Bashleben and M. Qasim Ansari
The Journal of Rheumatology March 2020, jrheum.190933; DOI: https://doi.org/10.3899/jrheum.190933
Stanley J. Naides
S.J. Naides, MD, Scientific Affairs, Euroimmun US, a PerkinElmer company, Mountain Lakes, New Jersey, and Diagnostic Immunology and Flow Cytometry Committee, College of American Pathologists, Northfield, Illinois; J.R. Genzen, MD, PhD, Diagnostic Immunology and Flow Cytometry Committee, College of American Pathologists, Northfield, Illinois, and Pathology, University of Utah / ARUP Laboratories, Salt Lake City, Utah; G. Abel, MD, PhD, Diagnostic Immunology and Flow Cytometry Committee, College of American Pathologists, Northfield, Illinois, and Laboratory Medicine and Pathology, Lahey Hospital & Medical Center, Beth Israel Lahey Health, Burlington, Massachusetts; C. Bashleben, MT, Diagnostic Immunology and Flow Cytometry Committee, College of American Pathologists, Northfield, Illinois; M.Q. Ansari, MD, Diagnostic Immunology and Flow Cytometry Committee, College of American Pathologists, Northfield, Illinois, and Pathology and Laboratory Medicine, Louis Stokes VAMC, Cleveland, Ohio, USA. This work was supported by the College of American Pathologists Diagnostic Immunology and Flow Cytometry Committee. Dr. S.J. Naides is employed by Euroimmun US. Dr. J.R. Genzen is employed by University of Utah/ARUP Laboratories, and is the principal investigator and contract researcher at ARUP Laboratories, Fujirebio Diagnostics. Address correspondence to Dr. S.J. Naides, Euroimmun US, 1 Bloomfield Avenue, Mountain Lakes, NJ 07046, USA. Email: stanley.naides@euroimmun.us. Accepted for publication February 28, 2020.
Jonathan R. Genzen
S.J. Naides, MD, Scientific Affairs, Euroimmun US, a PerkinElmer company, Mountain Lakes, New Jersey, and Diagnostic Immunology and Flow Cytometry Committee, College of American Pathologists, Northfield, Illinois; J.R. Genzen, MD, PhD, Diagnostic Immunology and Flow Cytometry Committee, College of American Pathologists, Northfield, Illinois, and Pathology, University of Utah / ARUP Laboratories, Salt Lake City, Utah; G. Abel, MD, PhD, Diagnostic Immunology and Flow Cytometry Committee, College of American Pathologists, Northfield, Illinois, and Laboratory Medicine and Pathology, Lahey Hospital & Medical Center, Beth Israel Lahey Health, Burlington, Massachusetts; C. Bashleben, MT, Diagnostic Immunology and Flow Cytometry Committee, College of American Pathologists, Northfield, Illinois; M.Q. Ansari, MD, Diagnostic Immunology and Flow Cytometry Committee, College of American Pathologists, Northfield, Illinois, and Pathology and Laboratory Medicine, Louis Stokes VAMC, Cleveland, Ohio, USA. This work was supported by the College of American Pathologists Diagnostic Immunology and Flow Cytometry Committee. Dr. S.J. Naides is employed by Euroimmun US. Dr. J.R. Genzen is employed by University of Utah/ARUP Laboratories, and is the principal investigator and contract researcher at ARUP Laboratories, Fujirebio Diagnostics. Address correspondence to Dr. S.J. Naides, Euroimmun US, 1 Bloomfield Avenue, Mountain Lakes, NJ 07046, USA. Email: stanley.naides@euroimmun.us. Accepted for publication February 28, 2020.
Gyorgy Abel
S.J. Naides, MD, Scientific Affairs, Euroimmun US, a PerkinElmer company, Mountain Lakes, New Jersey, and Diagnostic Immunology and Flow Cytometry Committee, College of American Pathologists, Northfield, Illinois; J.R. Genzen, MD, PhD, Diagnostic Immunology and Flow Cytometry Committee, College of American Pathologists, Northfield, Illinois, and Pathology, University of Utah / ARUP Laboratories, Salt Lake City, Utah; G. Abel, MD, PhD, Diagnostic Immunology and Flow Cytometry Committee, College of American Pathologists, Northfield, Illinois, and Laboratory Medicine and Pathology, Lahey Hospital & Medical Center, Beth Israel Lahey Health, Burlington, Massachusetts; C. Bashleben, MT, Diagnostic Immunology and Flow Cytometry Committee, College of American Pathologists, Northfield, Illinois; M.Q. Ansari, MD, Diagnostic Immunology and Flow Cytometry Committee, College of American Pathologists, Northfield, Illinois, and Pathology and Laboratory Medicine, Louis Stokes VAMC, Cleveland, Ohio, USA. This work was supported by the College of American Pathologists Diagnostic Immunology and Flow Cytometry Committee. Dr. S.J. Naides is employed by Euroimmun US. Dr. J.R. Genzen is employed by University of Utah/ARUP Laboratories, and is the principal investigator and contract researcher at ARUP Laboratories, Fujirebio Diagnostics. Address correspondence to Dr. S.J. Naides, Euroimmun US, 1 Bloomfield Avenue, Mountain Lakes, NJ 07046, USA. Email: stanley.naides@euroimmun.us. Accepted for publication February 28, 2020.
Christine Bashleben
S.J. Naides, MD, Scientific Affairs, Euroimmun US, a PerkinElmer company, Mountain Lakes, New Jersey, and Diagnostic Immunology and Flow Cytometry Committee, College of American Pathologists, Northfield, Illinois; J.R. Genzen, MD, PhD, Diagnostic Immunology and Flow Cytometry Committee, College of American Pathologists, Northfield, Illinois, and Pathology, University of Utah / ARUP Laboratories, Salt Lake City, Utah; G. Abel, MD, PhD, Diagnostic Immunology and Flow Cytometry Committee, College of American Pathologists, Northfield, Illinois, and Laboratory Medicine and Pathology, Lahey Hospital & Medical Center, Beth Israel Lahey Health, Burlington, Massachusetts; C. Bashleben, MT, Diagnostic Immunology and Flow Cytometry Committee, College of American Pathologists, Northfield, Illinois; M.Q. Ansari, MD, Diagnostic Immunology and Flow Cytometry Committee, College of American Pathologists, Northfield, Illinois, and Pathology and Laboratory Medicine, Louis Stokes VAMC, Cleveland, Ohio, USA. This work was supported by the College of American Pathologists Diagnostic Immunology and Flow Cytometry Committee. Dr. S.J. Naides is employed by Euroimmun US. Dr. J.R. Genzen is employed by University of Utah/ARUP Laboratories, and is the principal investigator and contract researcher at ARUP Laboratories, Fujirebio Diagnostics. Address correspondence to Dr. S.J. Naides, Euroimmun US, 1 Bloomfield Avenue, Mountain Lakes, NJ 07046, USA. Email: stanley.naides@euroimmun.us. Accepted for publication February 28, 2020.
M. Qasim Ansari
S.J. Naides, MD, Scientific Affairs, Euroimmun US, a PerkinElmer company, Mountain Lakes, New Jersey, and Diagnostic Immunology and Flow Cytometry Committee, College of American Pathologists, Northfield, Illinois; J.R. Genzen, MD, PhD, Diagnostic Immunology and Flow Cytometry Committee, College of American Pathologists, Northfield, Illinois, and Pathology, University of Utah / ARUP Laboratories, Salt Lake City, Utah; G. Abel, MD, PhD, Diagnostic Immunology and Flow Cytometry Committee, College of American Pathologists, Northfield, Illinois, and Laboratory Medicine and Pathology, Lahey Hospital & Medical Center, Beth Israel Lahey Health, Burlington, Massachusetts; C. Bashleben, MT, Diagnostic Immunology and Flow Cytometry Committee, College of American Pathologists, Northfield, Illinois; M.Q. Ansari, MD, Diagnostic Immunology and Flow Cytometry Committee, College of American Pathologists, Northfield, Illinois, and Pathology and Laboratory Medicine, Louis Stokes VAMC, Cleveland, Ohio, USA. This work was supported by the College of American Pathologists Diagnostic Immunology and Flow Cytometry Committee. Dr. S.J. Naides is employed by Euroimmun US. Dr. J.R. Genzen is employed by University of Utah/ARUP Laboratories, and is the principal investigator and contract researcher at ARUP Laboratories, Fujirebio Diagnostics. Address correspondence to Dr. S.J. Naides, Euroimmun US, 1 Bloomfield Avenue, Mountain Lakes, NJ 07046, USA. Email: stanley.naides@euroimmun.us. Accepted for publication February 28, 2020.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Antinuclear Antibodies Testing Method Variability: A Survey of Participants in the College of American Pathologists’ Proficiency Testing Program
Stanley J. Naides, Jonathan R. Genzen, Gyorgy Abel, Christine Bashleben, M. Qasim Ansari
The Journal of Rheumatology Mar 2020, jrheum.190933; DOI: 10.3899/jrheum.190933
Antinuclear Antibodies Testing Method Variability: A Survey of Participants in the College of American Pathologists’ Proficiency Testing Program
Stanley J. Naides, Jonathan R. Genzen, Gyorgy Abel, Christine Bashleben, M. Qasim Ansari
The Journal of Rheumatology Mar 2020, jrheum.190933; DOI: 10.3899/jrheum.190933